Clinical Trials Browser

Enrolling by invitation × Interventional × Cyclophosphamide × Clear all

Lymphoma, T-Cell, Peripheral

NCT07168486 2025-09-11

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Lymphoma, Follicular, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03328026 2025-02-04

Combination Study of SV-BR-1-GM With Retifanlimab

Phase 1/2 Enrolling by invitation

36 enrolled

Breast

Breast Neoplasms

Clinical Trials

BrEto-TCL

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Combination Study of SV-BR-1-GM With Retifanlimab